Ant Group IPO: Valuation Insights
Ant has launched its concurrent Hong Kong and STAR Market IPO to raise $34.4 billion. Overall, we think that the IPO price is reasonable for a...
366 Views
Lufax IPO Valuation: The Risk-Reward Profile Does Not Justify the Premium
In this insight, we evaluate the attractiveness of Lufax's IPO valuation compared to its peers. We believe the company shares are overvalued and...
385 Views
ECM Weekly (25 October 2020) - Ant Group, Lufax, JW Thera, Shimao Svcs, GDS Secondary, Nanofilm
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. This week...
326 Views
Lufax IPO: Valuation Insights
Our valuation analysis suggests that the IPO price range is unattractive and we would be inclined to give the IPO a pass.
577 Views
Lufax IPO - Stuck with the Earlier Fundraising Valuation
Lufax Holdings (LU US) aims to raise around US$2.4bn via its US listing. The company is backed by Ping An Insurance and has undergone major changes...
411 Views